Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: Report from the Research on Adverse Drug Events and Reports (RADAR) project

British Journal of Haematology

Volumn 135, Issue 5, 2006, Pages 642-650

  Bennett, Charles L ^a   Evens, Andrew M ^a   Andritsos, Leslie A ^b   Balasubramanian, Lakshmi ^a   Mai, Mark ^a   Fisher, Matthew J ^a   Kuzel, Timothy M ^a   Angelotta, Cara ^a   McKoy, June M ^a   Vose, Julie M ^c   Bierman, Philip J ^c   Kuter, David J ^d   Trifilio, Steven M ^a   Devine, Steven M ^b   Tallman, Martin S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Granulocyte colony stimulating factor; Haematopoietic growth factors; Megakaryocyte growth and development factor; Research on Adverse Drug Events and Reports

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOANTIBODY; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IDARUBICIN; MELPHALAN; METHOTREXATE; PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANEMIA; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; ERYTHROCYTE CONCENTRATE; FEMALE; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LARGE CELL LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; REMISSION; REVIEW; THROMBOCYTOPENIA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AUTOANTIBODIES; CLINICAL TRIALS; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MONOCYTIC, ACUTE; LYMPHOMA, B-CELL; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; THROMBOPOIETIN; TISSUE DONORS;

EID: 33750547396     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06312.x     Document Type: Review

References (43)

1. Ancliff, P.J., Gale, R.E., Liesner, R., Hann, I. & Linch, D.C. (2003) Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. British Journal of Haematology, 120, 685-690.
2. Anderlini, P., Chan, F.A., Champlin, R.E., Korbling, M. & Strom, S.S. (2002) Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development. Bone Marrow Transplantation, 30, 661-663.
3. Balaguer, H., Galmes, A., Ventayol, G., Bargay, J. & Besalduch, J. (2004) Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor. Transfusion, 44, 1260-1261.
4. Basser, R.L., O'Flaherty, E., Green, M., Edmonds, M., Nichol, J., Menchaca, D.M., Cohen, B. & Begley, C.G. (2002) Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood, 99, 2599-2602.
5. Bennett, C.L., Nebeker, J.R., Lyons, E.A., Samore, M.H., Feldman, M.D., McKoy, J.M., Carson, K.R., Belknap, S.M., Trifilio, S.M., Schumock, G.T., Yarnold, P.R., Davidson, C.J., Evens, A.M., Kuzel, T.M., Parada, J.P., Cournoyer, D., West, D.P., Sartor, O., Tallman, M.S. & Raisch, D.W. (2005) The Research on Adverse Drug Events and Reports (RADAR) project. Journal of the American Medical Association, 293, 2131-2140.
6. Bortin, M.M., D'Amaro, J., Bach, F.H., Rimm, A.A. & van Rood, J.J. (1987) HLA associations with leukemia. Blood, 70, 227-232.
7. Casadevall, N., Durieux, P., Dubois, S., Hemery, F., Lepage, E., Quarre, M.C., Damaj, G., Giraudier, S., Guerci, A., Laurent, G., Dombret, H., Chomienne, C., Ribrag, V., Stamatoullas, A., Marie, J.P., Vekhoff, A., Maloisel, F., Navarro, R., Dreyfus, F. & Fenaux, P. (2004) Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial. Blood, 104, 321-327.
8. Cavallaro, A.M., Lilleby, K., Majolino, I., Storb, R., Appelbaum, F.R., Rowley, S.D. & Bensinger, W.I. (2000) Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplantation, 25, 85-89.
9. Dincer, A.P., Gottschall, J. & Margolis, D.A. (2004) Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization. Journal of Pediatric Hematology Oncology, 26, 761-763.
10. Dombret, H., Chastang, C., Fenaux, P., Reiffers, J., Bordessoule, D., Bouabdallah, R., Mandelli, F., Ferrant, A., Auzanneau, G., Tilly, H., Yver, A., Degos, L., for the AML Cooperative Study Group. (1995) A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group. New England Journal of Medicine, 332, 1678-1683.
11. Donadieu, J., Leblanc, T., Bader Meunier, B., Barkaoui, M., Fenneteau, O., Bertrand, Y., Maier-Redelsperger, M., Micheau, M., Stephan, J.L., Phillipe, N., Bordigoni, P., Babin-Boilletot, A., Bensaid, P., Manel, A.M., Vilmer, E., Thuret, I., Blanche, S., Gluckman, E., Fischer, A., Mechinaud, F., Joly, B., Lamy, T., Hermine, O., Cassinat, B., Bellanne-Chantelot, C. & Chomienne, C. (2005) Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica, 90, 45-53.
12. Dong, F., Brynes, R.K., Tidow, N., Welte, K., Lowenberg, B. & Touw, I.P. (1995) Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. New England Journal of Medicine, 333, 487-493.
13. Graf, G., Zaborski, M., Quentmeier, H. & Drexler, H.G. (1996) Phorbol ester PMA induces expression of the thrombopoietin receptor MPL in leukemia cells. Leukemia & Lymphoma, 24, 149-157.
14. Harker, L.A., Roskos, L.K., Marzec, U.M., Carter, R.A., Cherry, J.K., Sundell, B., Cheung, E.N., Terry, D. & Sheridan, W. (2000) Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood, 95, 2514-2522.
15. Hasenclever, D. & Sextro, M. (1996) Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks. Bone Marrow Transplantation, 17(Suppl. 2), S28-S30.
16. Heil, G., Hoelzer, D., Sanz, M.A., Lechner, K., Liu Yin, J.A., Papa, G., Noens, L., Szer, J., Ganser, A., O'Brien, C., Matcham, J. & Barge, A. (1997) A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group. Blood, 90, 4710-4718.
17. Hellstrom-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I.M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Nilsson-Ehle, H., Samuelsson, J., Tangen, J.M., Winqvist, I., Oberg, G., Osterborg, A. & Ost, A. (1998) Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood, 92, 68-75.
18. Hershman, D., Neugut, A.I., Jacobson, J.S., Wang, J., Tsai, W.-Y., McBride, R., Bennett, C. & Grann, V.R. (2006) Acute leukemia/myelodysplasia risk following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. Journal of the National Cancer Institute, (in press).
19. Horowitz, M.M. & Confer, D.L. (2005) Evaluation of hematopoietic stem cell donors. American Society of Hematology Program Book, 469-475.
20. Jadersten, M., Montgomery, S.M., Dybedal, I., Porwit-MacDonald, A. & Hellstrom-Lindberg, E. (2005) Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood, 106, 803-811.
21. Jenkins, J., Williams, D. & Collins, D. (2005) SB-497115, A novel, oral platelet growth factor, increases platelet counts in healthy subjects [abstract]. Transfusion, 45, 1A.
22. Kaplinsky, C., Trakhtenbrot, L., Hardan, I., Reichart, M., Daniely, M., Toren, A., Amariglio, N., Rechavi, G. & Izraeli, S. (2003) Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF. Bone Marrow Transplantation, 32, 31-34.
23. Kuter, D.J., Goodnough, L.T., Romo, J., DiPersio, J., Peterson, R., Tomita, D., Sheridan, W. & McCullough, J. (2001) Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood, 98, 1339-1345.
24. Li, J., Yang, C., Xia, Y., Bertino, A., Glaspy, J., Roberts, M. & Kuter, D.J. (2001) Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood, 98, 3241-3248.
25. Makita, K., Ohta, K., Mugitani, A., Hagihara, K., Ohta, T., Yamane, T. & Hino, M. (2004) Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest. Bone Marrow Transplantation, 33, 661-665.
26. Mantovani, L., Lentini, G., Hentschel, B., Wickramanayake, P.D., Loeffler, M., Diehl, V. & Tesch, H. (2000) Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin. British Journal of Haematology, 109, 367-375.
27. Nagler, A., Korenstein-Ilan, A., Amiel, A. & Avivi, L. (2004) Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Experimental Hematology, 32, 122-130.
28. Negrin, R.S., Stein, R., Doherty, K., Cornwell, J., Vardiman, J., Krantz, S. & Greenberg, P.L. (1996) Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. Blood, 87, 4076-4081.
29. Pulsipher, M.A., Nagler, A., Iannone, R. & Nelson, R.M. (2006) Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatric Blood & Cancer, 46, 422-433.
30. Rosenberg, P.S., Alter, B.P., Bolyard, A.A., Bonilla, M.A., Boxer, L.A., Cham, B., Fier, C., Freedman, M., Kannourakis, G., Kinsey, S., Schwinzer, B., Zeidler, C., Welte, K. & Dale, D.C. (2006) The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood, 107, 4628-4635.
31. Rosenthal, J., Healey, T., Ellis, R., Gillan, E. & Cairo, M.S. (1996) A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life. Journal of Pediatrics, 128, 135-137.
32. Rowe, J.M., Andersen, J.W., Mazza, J.J., Bennett, J.M., Paietta, E., Hayes, F.A., Oette, D., Cassileth, P.A., Stadtmauer, E.A. & Wiernik, P.H. (1995) A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 year of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). Blood, 86, 457-462.
33. Rutella, S., Rumi, C., Pierelli, L., Morosetti, R., Sica, S., Bonanno, G., Scambia, G. & Leone, G. (2000) Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression. Experimental Hematology, 28, 612-625.
34. Sakamaki, S., Matsunaga, T., Hirayama, Y., Kuga, T. & Niitsu, Y. (1995) Haematological study of healthy volunteers 5 year after G-CSF. Lancet, 346, 1432-1433.
35. Shapira, M.Y., Kaspler, P., Samuel, S., Shoshan, S. & Or, R. (2003) Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors. American Journal of Hematology, 73, 33-36.
36. Shibuya, K., Kuwaki, T., Akahori, H., Kato, T. & Miyazaki, H. (2004) Pegylated recombinant human megakaryocyte growth and development factor suppresses the development of megakaryoblastic leukemia in mice. Leukamia Research, 28, 941-946.
37. Smith, R.E., Bryant, J., DeCillis, A. & Anderson, S. (2003) Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. Journal of Clinical Oncology, 21, 1195-1204.
38. Stone, R.M., Berg, D.T., George, S.L., Dodge, R.K., Paciucci, P.A., Schulman, P., Lee, E.J., Moore, J.O., Powell, B.L. & Schiffer, C.A. (1995) Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. New England Journal of Medicine, 332, 1671-1677.
39. Storek, J., Dawson, M.A. & Maloney, D.G. (2000) Normal T, B, and NK cell counts in healthy donors at 1 year after blood stem cell harvesting. Blood, 95, 2993-2994.
40. Stroncek, D., Shawker, T., Follmann, D. & Leitman, S.F. (2003) G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion, 43, 609-613.
41. Tassi, C., Tazzari, P.L., Bonifazi, F., Giudice, V., Nannetti, A., Ricci, F., Rizzi, S., Bandini, G. & Conte, R. (2005) Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study. Bone Marrow Transplantation, 36, 289-294.
42. Verdijk, R.M. (2002) Thrombopoietin in healthy donors. Blood, 99, 3867; author reply 3867-3868.
43. Yang, C., Xia, Y., Li, J. & Kuter, D. (1999) The appearance of anti-thrombopoietin antibody and circulating thrombopoietin-IgG complexes in a patient developing thrombocytopenia after the injection of PEG-rHuMGDF. Blood, 94, 681.